NASDAQ:CGC

Canopy Growth (CGC) Stock Price, News & Analysis

Canopy Growth logo
$0.43 -0.04 (-9.15%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$0.44 +0.01 (+1.87%)
As of 11/20/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Canopy Growth Stock (NASDAQ:CGC)

Advanced

Key Stats

Today's Range
$0.43
▼
$0.47
50-Day Range
$0.43
▼
$0.97
52-Week Range
$0.43
▼
$2.38
Volume
3.89 million shs
Average Volume
2.67 million shs
Market Capitalization
$180.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Canopy Growth is a Canadian cannabis company that produces and sells cannabis products for adult-use and medical markets. Its offerings include dried flower, oils, capsules, edibles, beverages and other cannabis formats, marketed under brands such as Tweed and 7ACRES.

The company also serves medical cannabis customers in international markets and has a presence in the cannabis vaporization business through Storz & Bickel. Its activities and product availability vary by market and are subject to local regulations.

Canopy Growth traces its origins to Tweed Marijuana Inc., established in 2013, and adopted the Canopy Growth name in 2015. The company is based in Smiths Falls, Ontario.

AI Generated. May Contain Errors.

Canopy Growth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

CGC MarketRank™: 
0.83567613157 of 5 stars

Canopy Growth scored higher than 17% of companies evaluated by MarketBeat, and ranked 784th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Canopy Growth has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Canopy Growth has only been the subject of 1 research reports in the past 90 days.

  • Read more about Canopy Growth's stock forecast and price target.
  • Earnings Growth

    Earnings for Canopy Growth are expected to grow in the coming year, from ($0.13) to ($0.10) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Canopy Growth is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Canopy Growth is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Canopy Growth has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.06% of the float of Canopy Growth has been sold short.
  • Short Interest Ratio / Days to Cover

    Canopy Growth has a short interest ratio ("days to cover") of 16.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Canopy Growth has recently decreased by 0.05%, indicating that investor sentiment is improving.
  • Dividend Yield

    Canopy Growth does not currently pay a dividend.

  • Dividend Growth

    Canopy Growth does not have a long track record of dividend growth.

  • News Sentiment

    Canopy Growth has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Canopy Growth this week, compared to 6 articles on an average week.
  • Search Interest

    Only 4 people have searched for CGC on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Canopy Growth to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Canopy Growth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $66,482.00 in company stock.

  • Percentage Held by Insiders

    0.35% of the stock of Canopy Growth is held by insiders.

  • Percentage Held by Institutions

    3.33% of the stock of Canopy Growth is held by institutions.

  • Read more about Canopy Growth's insider trading history.
Receive CGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CGC Stock News Headlines

$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
Why is Canopy Growth stock falling Friday?
See More Headlines

CGC Stock Analysis - Frequently Asked Questions

Canopy Growth's stock was trading at $1.14 at the beginning of the year. Since then, CGC shares have decreased by 62.5% and is now trading at $0.4270.

Canopy Growth Corporation (NASDAQ:CGC) posted its earnings results on Friday, November, 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.05. The business had revenue of $57.28 million for the quarter, compared to the consensus estimate of $57.72 million. Canopy Growth had a negative trailing twelve-month return on equity of 28.21% and a negative net margin of 73.03%.
Read the conference call transcript
.

Shares of Canopy Growth reverse split before market open on Wednesday, December 20th 2023.The 1-10 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Canopy Growth's top institutional investors include Goldman Sachs Group Inc. (0.32%) and Virtu Financial LLC (0.05%). Insiders that own company stock include Luc Mongeau, Christelle Gedeon, Thomas Carlton Stewart, Judy Eun Joo Hong, M Shan Atkins, Joseph Bayern, Theresa Yanofsky and Willy Kruh.
View institutional ownership trends
.

Shares of CGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Canopy Growth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), GE Aerospace (GE), Aurora Cannabis (ACB), Cronos Group (CRON) and Tilray Brands (TLRY).

Company Calendar

Last Earnings
11/06/2026
Today
11/22/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CGC
CIK
1737927
Fax
N/A
Employees
1,128
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$190.29 million
Net Margins
-73.03%
Pretax Margin
-73.91%
Return on Equity
-28.21%
Return on Assets
-17.97%

Debt

Debt-to-Equity Ratio
0.31
Current Ratio
2.82
Quick Ratio
2.20

Sales & Book Value

Annual Sales
$308.32 million
Price / Sales
0.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.10 per share
Price / Book
0.39

Miscellaneous

Outstanding Shares
423,353,000
Free Float
421,871,000
Market Cap
$180.77 million
Optionable
Optionable
Beta
0.87

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:CGC) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners